Calcineurin‐Inhibitor Discontinuation Could Reduce the Risk of De Novo Malignancies After Liver Transplantation for Alcohol‐Related Liver Disease

Documenti analoghi

• Adult Left Liver Transplantation With Mesocaval Shunt With Porto‐Mesenteric Disconnection: Long‐Term Outcome
  di: Jérôme Dumortier, et al.
  Pubblicazione: (2025)
• Alcohol Consumption After Listing for Liver Transplantation Is Associated With Increased Risk of Alcohol Consumption After Transplantation
  di: Léa Abrial, et al.
  Pubblicazione: (2025)
• Calcineurin Inhibitor Replacement With Mammalian Target of Rapamycin (mTOR) Inhibitor Following Lung Transplantation
  di: Kavya Kommaraju, et al.
  Pubblicazione: (2025)
• De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients
  di: Hanna L. Kleiboeker, et al.
  Pubblicazione: (2025)
• Sirolimus Plus Low‐Exposure Calcineurin Inhibitors as an Alternative Graft‐Versus‐Host Disease Prophylaxis in Calcineurin Inhibitor‐Intolerant Recipients: A Retrospective Study
  di: Yanfei Lu, et al.
  Pubblicazione: (2025)